ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag hiv art disease medicine science policy

DNA molecule.
Finding DNA Tags in AAV Stacks
Mariella Bodemeier Loayza Careaga, PhD | Mar 7, 2024 | 8 min read
Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 
Artist’s rendition of light blue monkeypox viruses in front of a black background.
FDA To Stretch Monkeypox Vaccine Supply via Intradermal Injection
Shafaq Zia | Aug 12, 2022 | 4 min read
The newly authorized intradermal vaccination only requires one-fifth of the usual vaccine dose. This will help stretch out the limited vaccine supply, experts say, but only if healthcare personnel receive sufficient training.
Alternative Medicines
The Scientist | Jul 1, 2012 | 10+ min read
As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.
Medicines for the World
Suerie Moon and Ellen â??t Hoen and Suerie Moon and Ellen â??t Hoen | Oct 1, 2012 | 5 min read
A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.
Turning Points: Making Policy, A Career
Karen Young Kreeger | Jun 9, 2002 | 2 min read
Passion leads many scientists away from the bench and into world policy organizations. But policy making and diplomacy require both art and science, and universities and fellowship programs can help life scientists acquire skills they don't always learn in their labs. Take Achal Bhatt, an analyst in the National Immunization Program (NIP) at the Centers for Disease Control and Prevention (CDC) in Atlanta. As Bhatt worked toward her PhD on mycobacteria, which cause tuberculosis, she became incre
Policy Aspects Of Science Dominate 1994 AAAS Meeting
Franklin Hoke | Feb 6, 1994 | 4 min read
About 5,000 scientists are expected to attend the 1994 annual meeting of the American Association for the Advancement of Science, to be held in San Francisco February 18-23. * John Gibbons, Assistant to the President of the United States for Science and Technology, and Director of the Office of Science and Technology Policy: "Science, Technology, and the Clinton Administration." * "Health Care Reform and Advances in Medicine":
Science, Policy Issues Put AIDS Vaccine On Slow Track
Myrna Watanabe | Nov 9, 1997 | 9 min read
The start of a clinical trial with an AIDS vaccine developed by French company Pasteur-Mérieux Connaught made front-page news in several major papers in September. The vaccine, composed of three HIV genes inserted into a canarypox vector, was administered to 420 human volunteers in a Phase II trial that tested the vaccine's safety and ability to provoke an immune response. Some researchers view the undertaking as one more trial of a technology that is unlikely to result in a useful compo
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020 | 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
Supplement: Art Caplan
Karen Pallarito | Jan 1, 2008 | 4 min read
Art Caplan By Karen Pallarito A conversation with Penn's renowned ethicist. RELATED ARTICLES Innovative Technology Daniel Skovronsky: Scientist and leader Turning Tobacco into Therapies Biofuel: The Potential Magic Bullet Britton Chance: Still searching for answers Technology Roundup DUSTIN FENSTERMACHER / WONDERFUL MACHINE As a Columbia University philosophy student in the 1970s, Arthur Caplan listened to ongoing discussions about the ethics of
Special Report
Surgisphere Sows Confusion About Another Unproven COVID-19 Drug
Catherine Offord | Jun 16, 2020 | 10+ min read
The company behind a now-discredited study on hydroxychloroquine also posted a report that has been cited by Latin American governments recommending ivermectin as a possible coronavirus treatment. Clinicians there say the effects have been extremely damaging.

Run a Search

ADVERTISEMENT